The gospel of men with hair loss: the effect of arthritis drugs is remarkable
November 17, 2016 Source: Bio Valley
Window._bd_share_config={ "common":{ "bdSnsKey":{ },"bdText":"","bdMini":"2","bdMiniList":false,"bdPic":"","bdStyle":" 0","bdSize":"16"},"share":{ }};with(document)0[(getElementsByTagName('head')[0]||body).appendChild(createElement('script')) .src='http://bdimg.share.baidu.com/static/api/js/share.js?v=89860593.js?cdnversion='+~(-new Date()/36e5)];A recent new study reported that two people who lost their hair, after taking an arthritis drug, actually grew up. The study once again proves that re-study of existing drugs is also of great significance compared to the development of new drugs. The study was completed by researchers in São Paulo, Brazil, and published in the Annals of Internal Medicine.
The two patients (a man and a woman) suffered from baldness many years ago, causing the hair to fall off. This disease causes the hair on the head to fall off completely because the immune system attacks the hair follicles of the head. There is no suitable treatment for this. The doctors of the two patients had tried multiple drug treatments and all failed. However, when they took an arthritis drug called tofatinib for two months, they started to have some hair on their heads. Not only that, but also some hair on their eyebrows and underarms. For the next nine months, the researchers tracked their physical condition and found no significant side effects.
Although hair loss and body hair loss are not fatal, the psychological impact on the patient is very serious. There are currently no very effective treatments or means. Researchers in Brazil hope that this type of tofatinib arthritis can cure people with alopecia. Although the study did not find serious side effects within 9 months, long-term clinical data on the drug showed that long-term use can cause serious side effects, including increased risk of infection in the eyes and stomach. The drug was developed by Pfizer and sold under the trade name Xeljan.
A study in September this year pointed out that in 66 patients, half of the hair was re-growed by tofadini, and one-third of the people had 50% of the hair. The effect was very obvious. Although the study lasted only three months, it has already shown the potential of the drug to become a new hair-developing drug. In this regard, more research is needed to confirm the safety of the drug as a hair growth drug. At the same time, it is necessary to study the mechanism of alopecia areata and the mechanism of the drug's germinal development, which is of great significance for people to improve their mental health and image.
Rapid Antigen Test,Virus Dignosis Test Kit,Covid-19 Detection Kit,Covid-19 Rapid Test Cassette
HANGZHOU DIAN BIOTECHNOLOGY CO., LTD. , https://www.dianbiotech.com